FBXO22 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.081400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.170600E-01
Normal-vs-Stage2
4.112200E-01
Normal-vs-Stage3
6.111400E-01
Normal-vs-Stage4
2.965000E-01
Stage1-vs-Stage2
5.550800E-01
Stage1-vs-Stage3
4.746300E-02
Stage1-vs-Stage4
7.950800E-01
Stage2-vs-Stage3
1.537220E-01
Stage2-vs-Stage4
8.062400E-01
Stage3-vs-Stage4
1.565570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.850400E-01
Normal-vs-AfricanAmerican
2.416400E-01
Normal-vs-Asian
6.816800E-01
Caucasian-vs-AfricanAmerican
9.792800E-01
Caucasian-vs-Asian
7.948400E-01
AfricanAmerican-vs-Asian
8.394000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.244200E-01
Normal-vs-Female
3.995800E-01
Male-vs-Female
9.757800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.319600E-01
Normal-vs-Age(41-60Yrs)
2.114000E-01
Normal-vs-Age(61-80Yrs)
5.520400E-01
Normal-vs-Age(81-100Yrs)
4.598000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.414800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.635600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.505200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.139800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.686800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.291200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.351600E-01
Normal-vs-Daily Drinker
7.321200E-01
Normal-vs-Weekly Drinker
5.904600E-01
Normal-vs-Occasional Drinker
1.597770E-01
Normal-vs-Social Drinker
4.448000E-01
Non Drinker-vs-Daily Drinker
2.762200E-01
Non Drinker-vs-Weekly Drinker
7.526600E-01
Non Drinker-vs-Occasional Drinker
5.470800E-01
Non Drinker-vs-Social Drinker
5.689200E-01
Daily Drinker-vs-Weekly Drinker
6.179400E-01
Daily Drinker-vs-Occasional Drinker
1.343000E-01
Daily Drinker-vs-Social Drinker
6.511000E-01
Weekly Drinker-vs-Occasional Drinker
4.742600E-01
Weekly Drinker-vs-Social Drinker
8.963600E-01
Occasional Drinker-vs-Social Drinker
2.550400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.448400E-01
Normal-vs-Grade 2
5.555700E-02
Normal-vs-Grade 3
5.380300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.118400E-03
Grade 1-vs-Grade 3
4.395400E-03
Grade 1-vs-Grade 4
6.448400E-01
Grade 2-vs-Grade 3
4.738200E-01
Grade 2-vs-Grade 4
5.555700E-02
Grade 3-vs-Grade 4
5.380300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.222800E-01
Normal-vs-NonDiabetic
4.084800E-01
Diabetic-vs-NonDiabetic
4.871000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.755980E-01
Normal-vs-NoPancreatitis
4.780000E-01
Pancreatitis-vs-NoPancreatitis
9.589800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.059200E-01
Normal-vs-N1
3.955000E-01
N0-vs-N1
4.246000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.838970E-01
Normal-vs-TP53-NonMutant
4.267400E-01
TP53-Mutant-vs-TP53-NonMutant
1.681390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
